A Novel Gene Signature Based on CDC20 and FCN3 for Prediction of Prognosis and Immune Features in Patients with Hepatocellular Carcinoma

Long-term survivals of patients with hepatocellular carcinoma (HCC) remain unfavorable, which is largely attributed to active carcinogenesis. Growing studies have suggested that the reliable gene signature could act as an independent prognosis factor for HCC patients. We tried to screen the survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Xing, Wu, Ya-kun, Hong, Guo-qing, Li, Jun-ke, Luo, Qing, Yuan, Jin, Dai, Guo-hua, Liu, Shuang-quan, Feng, Hua-guo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986430/
https://www.ncbi.nlm.nih.gov/pubmed/35402624
http://dx.doi.org/10.1155/2022/9117205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986430/
https://www.ncbi.nlm.nih.gov/pubmed/35402624
http://dx.doi.org/10.1155/2022/9117205

Ejemplares similares